In contrast, the inhibitors we used (phosphoramidon and phenanthroline) to model anthrax therapy are not considered as LT inhibitors [47], however in our experiments both of these substances increased survival during ciprofloxacin therapy, which was initiated at 24 h and 48 h post challenge. The gene discussed is LTA; the disease is anthrax infection.